Related Experiment Videos
Antiemetic guidelines: creating a more practical treatment approach
Jim M Koeller1, Matti S Aapro, Richard J Gralla
1University of Texas Health Science Center at San Antonio, Pharmacotherapy--MSC 6220, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA. koeller@uthscsa.edu
Summary
New guidelines simplify antiemetic use for chemotherapy-induced nausea and vomiting (CINV). This practical approach helps clinicians manage CINV over a 4-5 day period, improving patient care.
Area of Science:
- Oncology
- Pharmacology
- Clinical Practice Guidelines
Background:
- Existing antiemetic guidelines for chemotherapy-induced nausea and vomiting (CINV) have limited adoption.
- Practitioners may not consistently adhere to current recommendations for CINV management.
Purpose of the Study:
- To develop a simpler, more practical approach to antiemetic use in CINV.
- To clarify existing guidelines and provide an evidence-based document for daily clinical practice.
Main Methods:
- A consensus group revised existing antiemetic guidelines.
- Chemotherapy-induced nausea and vomiting (CINV) is reframed as a single process over 4-5 days.
- Three tables were created: emetic risk, treatment options, and dosing recommendations.
Main Results:
- A simplified, practical framework for antiemetic selection and management was developed.
- The new approach considers CINV as a continuous process, not just acute and delayed phases.
- Tables provide clear guidance on chemotherapy emetic risk, treatment choices, and drug dosages.
Conclusions:
- The revised guidelines offer a more straightforward method for practitioners to select and administer antiemetics.
- This practical document aims to improve the management of chemotherapy-induced nausea and vomiting.
- The approach represents a step forward in optimizing antiemetic therapy for cancer patients.